PNC Financial Services Group’s Definium Therapeutics DFTX Stock Holding History

PNC Financial Services Group’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$80.5K	Sell	2,116 -6,453	-75%	-$272K	﹤0.01%	3096
2026 Q2	$403K	Buy	8,569 +949	+12%	+$23.5K	﹤0.01%	1951
2026 Q1	$144K	Buy	7,620 +532	+8%	+$9.03K	﹤0.01%	2561
2025 Q4	$94.9K	Buy	7,088 +7,059	+24,341%	+$87.4K	﹤0.01%	2835
2025 Q3	$342	Buy	29 +12	+71%	+$112	﹤0.01%	4863
2025 Q2	$110	Buy	+17	New	+$112	﹤0.01%	4831
2022 Q4	–	Sell	-13,535	Closed	-$47K	–	4827
2022 Q3	$47K	Sell	13,535 -1	-0%	-$10	﹤0.01%	3014
2022 Q2	$130K	Buy	+13,536	New	+$171K	﹤0.01%	2401
2022 Q1	–	Sell	-160	Closed	-$3K	–	4641
2021 Q4	$3K	Hold	160	–	–	﹤0.01%	4081
2021 Q3	$5K	Hold	160	–	–	﹤0.01%	3941
2021 Q2	$8K	Buy	+160	New	+$8.4K	﹤0.01%	3768

Other funds holding DFTX

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

Patient Square Capital Menlo Park, California $627M AUM 115.4% 1-Year Est. Return

PNC Financial Services Group's DFTX Position: Q3 2026 in Review

PNC Financial Services Group reduced its Definium Therapeutics (DFTX) stake by 75% in Q3 2026, selling an estimated $272K and leaving 2,116 shares worth $80.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3096.

PNC Financial Services Group first reported a position in DFTX in Q2 2021 and has held it in 11 quarters since. The position peaked at $403K in Q2 2026. 166 funds tracked by Wall St. Rank hold DFTX as of Q3 2026.

PNC Financial Services Group held 2,116 shares of Definium Therapeutics worth $80.5K as of Q3 2026.
PNC Financial Services Group sold 6,453 Definium Therapeutics shares in Q3 2026, an estimated $272K.
Definium Therapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #3096 holding.
PNC Financial Services Group first reported a position in Definium Therapeutics in Q2 2021 and has held it in 11 quarters since.
PNC Financial Services Group's Definium Therapeutics position peaked at $403K in Q2 2026.
166 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2026.

Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.